Delivery Order SPE2DB22D3501-SPE2DB25FXD25
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $54,189.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Voranigo 40 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $54,189.90 and employs firm fixed pricing, with an ultimate completion date of September 16, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and...
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on August 25, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $162,569.70 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating that it was competed among all eligible vendors in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Voranigo 40 mg tablets (30-count units) valued at $27,094.95 under a firm fixed-price contract type. The contract is non-competitive set-aside and is scheduled for completion by September 19, 2025. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95. The delivery order was competitively awarded without set-aside designations on August 21, 2025, with an ultimate completion date of September 12, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as the place of performance for this...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95 and an ultimate completion date of August 8, 2025. This is a non-set-aside, competitively awarded delivery order utilizing an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $27,094.95 delivery order to AmerisourceBergen Drug Corp for Voranigo 40 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $27,094.95 by the Defense Logistics Agency on August 14, 2025, for the supply of Voranigo 40 mg tablets (30-count units). This non-set-aside competitive award is scheduled for completion by September 5, 2025, with performance taking place at the company's Conshohocken facility. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $54,189.90 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VORANIGO 40 MG TABLET 30S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXD25Delivery Order
The Defense Logistics Agency awarded a $54,419.24 delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 10 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive, competitively awarded transaction executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serves as a primary pharmaceutical distributor supporting federal medical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems, the Defense Health Agency, and other federal healthcare customers. AmerisourceBergen's contract portfolio demonstrates consistent performance across multiple therapeutic domains, positioning the company as a critical vendor within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.4k | 9/3/25 |